Estetrol‐Drospirenone combination oral contraceptive: a clinical study of contraceptive efficacy, bleeding pattern and safety in Europe and Russia

OBJECTIVES: To assess the contraceptive efficacy, bleeding pattern and safety of a combined oral contraceptive containing estetrol (E4) 15 mg and drospirenone (DRSP) 3 mg. DESIGN: Multicenter, open‐label, phase 3 trial. SETTING: Sixty‐nine sites in Europe and Russia. POPULATION: Sexually active wome...

Descripción completa

Detalles Bibliográficos
Autores principales: Gemzell‐Danielsson, K, Apter, D, Zatik, J, Weyers, S, Piltonen, T, Suturina, L, Apolikhina, I, Jost, M, Creinin, MD, Foidart, J‐M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290720/
https://www.ncbi.nlm.nih.gov/pubmed/34245666
http://dx.doi.org/10.1111/1471-0528.16840

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290720/
https://www.ncbi.nlm.nih.gov/pubmed/34245666
http://dx.doi.org/10.1111/1471-0528.16840

Ejemplares similares